Absolute Quantitation
Quantification of sphingolipid biosynthesis phosphate intermediates, sphinganines, ceramides, sphingomyelins, sulfatides, cerebrosides, and gangliosides by UPLC-MRM/MS.
Absolute Quantitation
Quantification of sphingolipid biosynthesis phosphate intermediates, sphinganines, ceramides, sphingomyelins, sulfatides, cerebrosides, and gangliosides by UPLC-MRM/MS.
Tissue: 10 mg
Cell: 2×10^6
Blood/plasma/serum: 20 µL
Urine: 50 µL
Plant: N/A
Feces: 5 mg
DBS: 20 µL
Synthesis precursors,
intermediate phosphates,
ceramides,
sphimgomyelins,
cerabrosides
selected gangliosides
Sphingolipid synthesis and metabolism
Name | HMDB ID | Super Class | Class |
06:0 SM (d18:1/6:0) | |||
12:0 Dihydro SM (d18:0/12:0) | |||
12:0 SM (d18:1/12:0) | |||
14:0 SM (d18:1/14:0) | |||
3-Keto Sphinganine | |||
C02 Dihydroceramide (d18:0/2:0) | |||
C06 Ceramide (d18:1/6:0) | |||
C06 Dihydroceramide (d18:0/6:0) | |||
C08 Ceramide (d18:1.8:0) | |||
C08 Dihydroceramide (d18:0/8:0) | |||
C08 Galactosyl(Ã) Ceramide (d18:1/08:0) | |||
C08 Lactosyl(Ã) Ceramide (d18:1/08:0) | |||
C10 Ceramide (d18:1/10:0) | |||
C12 Ceramide (d18:1/12:0) | |||
C12 Dihydroceramide (d18:0/12:0) | |||
C12 Galactosyl(Ã) Ceramide (d18:1/12:0) | |||
C12 Glucosyl(Ã) Ceramide (d18:1/12:0) | |||
C12 Lactosyl(Ã) Ceramide (d18:1/12:0) | |||
C14 Ceramide (d18:1/14:0) | |||
C14 dihydroceramide (d18:0/14:0) | |||
C16 Ceramide (d18:1/16:0) | |||
C16 Ceramide-1-phosphate (d18:1/16:0) | |||
C16 dihydro Ceramide (d18:0/16:0) | |||
C16 Dihydroceramide (d18:0/16:0) | |||
C16 Dihydroceramide-1-Phosphate (d18:0/16:0) | |||
C16 Galactosyl(Ã) Ceramide (d18:1/16:0) | |||
C16 Glucosyl(Ã) Ceramide (d18:1/14:0) | |||
C16 Glucosyl(Ã) Ceramide (d18:1/16:0) | |||
C16 Lactosyl(Ã) Ceramide (d18:1/14:0) | |||
C16 Lactosyl(Ã) Ceramide (d18:1/16:0) | |||
C16 Sphingomyelin (d18:1/16:0) | |||
C16:1 Sphingomyelin(SM) (d18:1/16:1(9Z)) | |||
C17 dihydro Ceramide (d18:0/17:0) | |||
C17 Sphingomyelin (d18:1/17:0) | |||
C18 Ceramide (d18:1/18:0) | |||
C18 Dihydroceramide (d18:0/18:0) | |||
C18 Galactosyl(Ã) Ceramide (d18:1/18:0) | |||
C18 Glucosyl(Ã) Ceramide (d18:1/18:0) | |||
C18 Glucosyl(Ã) Ceramide (d18:1/20:0) | |||
C18 Glucosyl(Ã) Ceramide (d18:1/22:0) | |||
C18 Sphingomyelin (d18:1/18:0) | |||
C18:1 Ceramide (d18:1/18:1(9Z)) | |||
C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) | |||
C18:1 Dihydroceramide (d18:0/18:1(9Z)) | |||
C18:1 Galactosyl(Ã) Ceramide (d18:1/18:1(9Z)) | |||
C18:1 Glucosyl(Ã) Ceramide (d18:1/18:1(9Z)) | |||
C18:1 Lactosyl(Ã) Ceramide (d18:1/18:0) | |||
C18:1 Lactosyl(Ã) Ceramide (d18:1/18:1) | |||
C18:1 Lactosyl(Ã) Ceramide (d18:1/20:0) | |||
C18:1 Lactosyl(Ã) Ceramide (d18:1/22:0) | |||
C18:1 Sphingomyelin (d18:1/18:1) | |||
C19 Ceramide (d18:1/19:0) | |||
C20 Ceramide (d18:1/20:0) | |||
C20:0 Sphingomyelin (d18:1/20:0) | |||
C22 Ceramide (d18:1/22:0) | |||
C22:0 Sphingomyelin (d18:1/22:0) | |||
C24 Ceramide (d18:1/24:0) | |||
C24 Dihydroceramide (d18:0/24:0) | |||
C24 Dihydroceramide-1-Phosphate (d18:0/24:0) | |||
C24 Lactosyl(Ã) Ceramide (d18:1/24:0) | |||
C24:1 Ceramide (d18:1/24:1(15Z)) | |||
C24:1 Dihydroceramide (d18:0/24:1(15Z)) | |||
C24:1 Galactosyl(Ã) Ceramide (d18:1/24:1(15Z)) | |||
C24:1 Glucosyl(Ã) Ceramide (d18:1/24:0) | |||
C24:1 Glucosyl(Ã) Ceramide (d18:1/24:1(15Z)) | |||
C24:1 Lactosyl(Ã) Ceramide (d18:1/24:1) | |||
C8 Glucosyl(Ã) Ceramide (d18:1/8:0) | |||
Galactosylsphingosine (d18:1) | |||
Glucosyl (Ã) Sphingosine (d20:1) | |||
Glucosyl Sphingosine (d18:1) | |||
Lactosyl(Ã) Sphingosine (d18:1) | |||
Lyso SM (d17:1) | |||
Lyso SM (dihydro) (d18:0) | |||
Lyso SM(d18:1) | |||
N-16:0 Phytosphingosine (t18:0/16:0) | |||
N-2′-OH C18 D-ribo Phytosphingosine | |||
N-C18 Phytoceramide (t18:0/18:0) | |||
Sphinganine (d16:0 | |||
Sphinganine (d20:0) | |||
Sphinganine-1-phosphate (d18:0) | |||
Sphingomyelin(SM) (d18:1/24:0) | |||
Sphingomyelin(SM) (d18:1/24:1) | |||
Sphingosine (d18:1) | |||
Sphingosine-1-phosphate (d16:1) | |||
Sphingosine-1-phosphate (d17:1) | |||
Sphingosine-1-phosphate (S1P) (d18:1) | |||
D-ribo-Phytosphingosine-1-Phosphate | Lipids and lipid-like molecules | Sphingolipids | |
1-Deoxysphinganine | Organic nitrogen compounds | Organonitrogen compounds | |
1-Desoxymethylsphinganine | Organic nitrogen compounds | Organonitrogen compounds | |
Sphinganine (d18:0) | Organic nitrogen compounds | Organonitrogen compounds |
We request that any publications, posters, or oral presentations resulting from work performed by The Metabolomics Innovation Centre acknowledge TMIC. This allows the Centre to report information such as impact on Canadian researchers to our funding agencies. Clients should also keep us apprised of any publications, posters, or oral presentations arising from work performed at TMIC.